Przemysław Stanisław Sareło

Dr. Przemysław Stanisław Sareło

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2025 in Materials
Verified
Journal Article
Open access
PDF file
ABAnna Błaszczyk-Pośpiech
Anna Błaszczyk-Pośpiech
NSNatalia Struzik
Natalia Struzik
MSMaria Szymonowicz
Maria Szymonowicz
PSPrzemysław Stanisław Sareło
Przemysław Stanisław Sareło
MWMaria Wiśniewska-Wrona
Maria Wiśniewska-Wrona
MWMagdalena Wawrzynska
Magdalena Wawrzynska
Endodontic sealers are crucial for achieving an effective root canal obturation, preventing reinfection and promoting long-term treatment success. This review categorizes sealers by chemical composition, including traditional types such as zinc oxide-eugenol, glass ionomer, silicone, methacrylate and epoxy resins, calcium hydroxide, and the latest bioceramic formulations. Each type is evaluated for its physicochemical properties, biocompatibility, sealing ability, antimicrobial activity, and clinical limitations. A significant focus is placed on recent research into modifications of these materials with antimicrobial agents, aimed at improving antibacterial properties, bioactivity, and sealing performance. Among these, chitosan emerges as the most promising additive due to its broad antimicrobial spectrum, low cytotoxicity, and enhancement of sealing capacity. While bioceramic sealers represent a notable advancement due to their bioactivity and favorable interaction with moist environments, concerns regarding potential neurotoxicity and retreatability remain. The article presents recent advancements in the enhancement of endodontic sealers through the incorporation of organic and inorganic additives. It further delineates key research priorities, particularly the integration of bioactive materials, nanotechnology, and naturally derived compounds, with an emphasis on their potential applications in pediatric endodontics. Overall, while contemporary sealers offer a wide range of benefits, continued innovation is needed to optimize their biological safety, mechanical performance, and clinical usability.

Verified
Journal Article
Open access
PDF file
MZMagdalena Zaręba
Magdalena Zaręba
PSPrzemysław Stanisław Sareło
Przemysław Stanisław Sareło
MKMarta Kopaczyńska
Marta Kopaczyńska
ABAgata Białońska
Agata Białońska
ŁUŁukasz Uram
Łukasz Uram
SWStanislaw Wolowiec
Stanislaw Wolowiec
Polyhydroxylated dendrimer was synthesized from poly(amidoamine) (PAMAM) dendrimer generation 3 by addition of glycidol (G3gl). G3gl megamer was further modified by binding PAMAM G0 dendrimers by activation of G3gl with p-nitrophenylchloroformate, followed by the addition of excess PAMAM G0 and purification using dialysis. The maximum G0 binding capacity of G3gl was 12 in the case when G0 was equipped with two covalently attached nimesulide equivalents. Nimesulide (N) was converted into N-(p-nitrophenyl) carbonate derivative and fully characterized using X-ray crystallography and spectral methods. Nimesulide was then attached to G0 via a urea bond to yield G02N. The mixed generation G3gl–G02N megamer was characterized using 1H NMR spectroscopy, and its molecular weight was estimated to be 22.4 kDa. The AFM image of G3gl–G02N deposited on mica demonstrated aggregation of nimesulide-covered megamer. The height of the deposited megamer was 8.5 nm. The megameric conjugate with nimesulide was tested in vitro on three human cell lines: squamous cell carcinoma (SCC-15) and glioblastoma (U-118 MG) overexpressing cyclooxygenase-2 (COX-2), and normal skin fibroblasts (BJ). The conjugate efficiently penetrated into all cells and was more cytotoxic against SCC-15 than against BJ. Moreover, the conjugate produced a strong and selective antiproliferative effect on both cancer cell lines (IC50 < 7.5 µM).

26 February 2023 in Biocybernetics and Biomedical Engineering
Verified
Journal Article
Closed access
PSPrzemysław Stanisław Sareło
Przemysław Stanisław Sareło
BSBeata Magdalena Sobieszczańska
Beata Magdalena Sobieszczańska
EWEdyta Wysokińska
Edyta Wysokińska
MGMarlena Gąsior-Głogowska
Marlena Gąsior-Głogowska
WKWojciech Kalas
Wojciech Kalas
MKMarta Kopaczyńska
Marta Kopaczyńska

10 December 2020 in Materials
Verified
Journal Article
Open access
PDF file
PSPrzemysław Stanisław Sareło
Przemysław Stanisław Sareło
MDMaciej Duda
Maciej Duda
MGMarlena Gąsior-Głogowska
Marlena Gąsior-Głogowska
EWEdyta Wysokińska
Edyta Wysokińska
WKWojciech Kalas
Wojciech Kalas
MKMarta Kopaczyńska
Marta Kopaczyńska
Current vascular stents, such as drug eluting stents (DES), have some serious drawbacks, like in stent restenosis and thrombosis. Therefore, other solutions are sought to overcome these post-implantations complications. These include the strategy of biofunctionalization of the stent surface with antibodies that facilitate adhesion of endothelial cells (ECs) or endothelial progenitor cells (EPCs). Rapid re-endothelialization of the surface minimizes the risk of possible complications. In this study, we proposed ammonium acryloyldimethyltaurate/vinylpyrrolidone co-polymer-based surface (AVC), which was mercaptosilanized in order to expose free thiol groups. The presence of free thiol groups allowed for the covalent attachment of CD133 antibodies by disulfide bridges formation between mercaptosilanized surface and cysteine of the protein molecule thiol groups. Various examinations were performed in order to validate the procedure, including attenuated total reflection–Fourier transform infrared spectroscopy (ATR-FTIR) and Fourier transform Raman spectroscopy (FT-Raman), atomic force microscopy (AFM) and scanning electron microscopy (SEM). By means of ATR-FTIR spectroscopy presence of the CD133 antibody within coating was confirmed. In vitro studies proved good biocompatibility for blood cells without induction of hemolytic response. Thus, proposed biofunctionalized CD133 antibody AVC surface has shown sufficient stability for adapting as cardiovascular implant coating and biocompatibility. According to conducted in vitro studies, the modified surface can be further tested for applications in various biological systems.

Verified
Journal Article
Open access
PDF file
PSPrzemysław Stanisław Sareło
Przemysław Stanisław Sareło
MWMaria Wiśniewska-Wrona
Maria Wiśniewska-Wrona
MSMonika Sikora
Monika Sikora
BMBartosz Mielan
Bartosz Mielan
YGYuriy Gerasymchuk
Yuriy Gerasymchuk
MWMagdalena Wawrzynska
Magdalena Wawrzynska
Chronic infected wounds remain a major medical challenge, particularly in the context of increasing antibiotic resistance. The objective of this study was to develop and evaluate chitosan-based (CS) sponges enhanced with graphene oxide (GO) as potential antimicrobial wound dressings. The composite sponges were fabricated using microcrystalline CS (MKCh) and 5% (w/w) GO, followed by freeze-drying and γ-sterilization (25 kGy). Physico-mechanical characterization showed that GO incorporation did not significantly alter tensile strength, while absorption and sorption capacities were improved, especially after sterilization. Structural and spectroscopic analyses confirmed increased porosity and molecular interaction between CS and GO. Cytocompatibility was verified in vitro using L-929 fibroblasts, with no cytotoxic effects observed in indirect contact. Antimicrobial activity tests demonstrated that GO-modified dressings exhibited enhanced activity against E. coli and S. aureus, though results were strain-dependent and not uniformly superior to CS alone. Notably, antifungal efficacy against C. albicans was reduced with GO addition. Overall, the developed GO-enriched CS sponges present favorable biocompatibility, mechanical resilience, and selective antimicrobial activity, supporting their potential application in chronic wound management. Further optimization of GO concentration and formulation is warranted to maximize antimicrobial efficacy across a broader spectrum of pathogens.

1 April 2022 in Experimental Eye Research
Verified
Journal Article
Closed access
MDMonika E. Danielewska
Monika E. Danielewska
MKMałgorzata A. Kostyszak
Małgorzata A. Kostyszak
PSPrzemysław Stanisław Sareło
Przemysław Stanisław Sareło
MGMarlena Gąsior-Głogowska
Marlena Gąsior-Głogowska
MNMarcela Niemczyk
Marcela Niemczyk
DID. Robert Iskander
D. Robert Iskander